Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001640334-24-001815
Filing Date
2024-12-03
Accepted
2024-12-03 20:30:52
Documents
1
Period of Report
2024-11-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3076
  Complete submission text file 0001640334-24-001815.txt   4600
Mailing Address 2620 REGATTA DRIVE SUITE 102 LAS VEGAS NV 89128
Business Address 2620 REGATTA DRIVE SUITE 102 LAS VEGAS NV 89128 (702) 659-8829
BIOADAPTIVES, INC. (Issuer) CIK: 0001575142 (see all company filings)

EIN.: 462592228 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2620 REGATTA DR. SUITE 102 LAS VEGAS NV 89128
Business Address
Dissanayake Gimhana Sasanka (Reporting) CIK: 0002046704 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54949 | Film No.: 241524484